Clinical Trial Update: A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil [NA]

View source ↗

Summary

A completed clinical trial investigating minocycline and armodafinil to reduce symptom burden from chemoradiation in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Armodafinil (armodafinil)
• Minocycline (minocycline)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | NA | Status: COMPLETED | Results posted: 2020-02-10